Aurobindo Pharma Sustainability Profile
Aurobindo Pharma Limited, commonly known as Aurobindo Pharma, is a prominent player in the global pharmaceutical industry, headquartered in Hyderabad, India. Founded in 1986, the company has established a strong presence in over 150 countries, with significant operations across North America, Europe, and Asia. Specialising in the manufacture of generic pharmaceuticals, Aurobindo Pharma offers a diverse portfolio that includes formulations, active pharmaceutical ingredients (APIs), and biosimilars. The company is recognised for its commitment to quality and innovation, which has propelled it to a leading position in the market. With numerous regulatory approvals and a robust pipeline of products, Aurobindo Pharma continues to achieve notable milestones, solidifying its reputation as a trusted provider of affordable healthcare solutions worldwide.
DitchCarbon Score
How does Aurobindo Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aurobindo Pharma's score of 33 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aurobindo Pharma's reported carbon emissions
In 2025, Aurobindo Pharma reported total carbon emissions of approximately 1,225,388,000 kg CO2e, with emissions distributed across various scopes: 750,616,000 kg CO2e from Scope 1, 474,772,000 kg CO2e from Scope 2, and 11,031,000 kg CO2e from capital goods within Scope 3. The company has set ambitious targets to reduce its carbon footprint by 12.5% for both Scope 1 and Scope 2 emissions by 2025, aligning with the Science Based Targets initiative (SBTi) to remain well below a 2°C increase in global temperatures. In 2024, Aurobindo Pharma's total emissions were approximately 967,471,000 kg CO2e, with Scope 1 emissions at 414,356,000 kg CO2e and Scope 2 emissions at 553,115,000 kg CO2e. The previous year, 2023, saw total emissions of about 941,472,000 kg CO2e, with Scope 1 at 447,207,000 kg CO2e and Scope 2 at 494,264,000 kg CO2e. The company has consistently reported emissions data, demonstrating transparency in its climate commitments. Aurobindo Pharma's initiatives reflect a proactive approach to addressing climate change, with a clear focus on reducing its operational carbon footprint in the coming years.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 409,572,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 523,611,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 |
How Carbon Intensive is Aurobindo Pharma's Industry?
How Carbon Intensive is Aurobindo Pharma's Location?
Aurobindo Pharma's Scope 3 Categories Breakdown
Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 23% of total emissions under the GHG Protocol, with "Fuel and Energy Related Activities" being the largest emissions source at 69% of Scope 3 emissions.
Top Scope 3 Categories
Aurobindo Pharma's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aurobindo Pharma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
